Companies: 10,795·Total market cap: $144.5T
Replimune Group, Inc.

Replimune Group, Inc.

REPLNASDAQHealthcare● Active
$8.97
$-0.50(-5.28%)
Market Cap$740676392
P/E Ratio
52W High$13.24
52W Low$1.5

Replimune Group, Inc. (REPL) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

REPL · net income · updated Jun 8, 2026

Core profitability metrics

Net income was −$247.3M for FY2025 (fiscal year ending 2025-03-31), down 14.6% year-over-year. Net profit margin was —.

FY2025 Net Income−$247.3M▼ -14.6% YoY
Trailing 12M (TTM)−$314.9Mtrailing 4 quarters sum
Net Profit Margin
YoY Change-14.6%
5-Year CAGRN/AN/A — contains loss years
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · REPL net income history · REPL profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025Loss−$247.3M▼ 14.6%
FY2024Loss−$215.8M▼ 23.8%
FY2023Loss−$174.3M▼ 47.7%
FY2022Loss−$118.0M▼ 46.0%
FY2021Loss−$80.9M▼ 53.7%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Replimune Group, Inc.
Replimune Group, Inc.YOU
REPL
−$247.3M-14.6%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Replimune Group, Inc. (REPL) reported net income of −$247.3M for FY2025 (fiscal year ending 2025-03-31), down 14.6% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Replimune Group, Inc. has not yet achieved annual profitability based on available data (9 fiscal years). The company has reported net losses across all available periods.

Replimune Group, Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Replimune Group, Inc. net worth" — the company's market capitalization is a separate figure from REPL net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

REPL net income · 4 questions

Replimune Group, Inc. is not currently profitable on an annual basis. The company reported a net loss of $247.3M for FY2025.

is REPL profitabledoes REPL make a profitREPL profitabilityREPL profitable company

Source: FMP /income-statement · GAAP · Replimune Group, Inc. · Replimune Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026